Romosozumab versus Alendronate and Fracture Risk in Women with Osteoporosis
- PMID: 29320649
- DOI: 10.1056/NEJMc1714810
Romosozumab versus Alendronate and Fracture Risk in Women with Osteoporosis
Comment on
-
Romosozumab versus Alendronate and Fracture Risk in Women with Osteoporosis.N Engl J Med. 2018 Jan 11;378(2):194. doi: 10.1056/NEJMc1714810. N Engl J Med. 2018. PMID: 29322751 No abstract available.
-
Romosozumab versus Alendronate and Fracture Risk in Women with Osteoporosis.N Engl J Med. 2018 Jan 11;378(2):194-5. doi: 10.1056/NEJMc1714810. N Engl J Med. 2018. PMID: 29322752 No abstract available.
-
Romosozumab versus Alendronate and Fracture Risk in Women with Osteoporosis.N Engl J Med. 2018 Jan 11;378(2):195. doi: 10.1056/NEJMc1714810. N Engl J Med. 2018. PMID: 29322753 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical